Viveve – 2018 Viveve RF Vaginal Rejuvenation
SKU: 220916F
Viveve – RF Vaginal Rejuvenation
SOLD – NO LONGER AVAILABLE
Mfg. 6/2018
Includes: Manual, Handpiece, Console, 4 Treatment Tips, 7 bxs coupling fluid, 6 elec grounding pads, 10 cryo cannisters, footpedal, manaul, 110v
Power Requirements: 110V powered, standard for any office (100-240V, 50/60Hz).
Reason for Selling: Physician is Retiring and closing his business
Consumables: Treatment Tips are Single Use and Cost $500 per Tip
Recertification Fee Cost: Currently manufacturer does not charge a re-certification fee to purchase consumables.
The Viveve System provides sustained tissue tightening and strengthening by substantially heating the tissue at depth. The Viveve System’s patented, cryogen-cooled monopolar radiofrequency (CMRF) is unique in its ability to deliver volumetric heat (90 J/cm2) in order to stimulate robust neocollagenesis. This can be accomplished in just ONE session.
The Viveve® System, formerly known as Geneveve®, provides the only single treatment option to resolve vaginal laxity, incontinence, and dryness. It is a fantastic choice for women who desire a one-time 25-minute procedure to improve symptoms of laxity or loss of sensation, urge incontinence, stress incontinence, and overactive bladder. The Viveve® System treatment uses clinically-proven cryogen-cooled monopolar radiofrequency (CMRF) to uniformly deliver gentle volumetric heating while cooling delicate surface tissue. This unique technology stimulates the body’s natural collagen formation process. Doctors and patients report the procedure using The Viveve® System delivers a noticeable tightening of the entire vaginal barrel for increased friction and pleasure during sexual intimacy, greater bladder control, and more youthful vaginal tissue.
REQUEST MORE INFORMATION
80+ name brands to choose from
Serving over 4,500 Med Spas nationwide
Get money for your old equipment
Related Products
Original price was: $3,500.00.$2,995.00Current price is: $2,995.00.
14% Off
Reviews
There are no reviews yet.